4.3 Article

Snakebites and climate change in California, 1997-2017

Journal

CLINICAL TOXICOLOGY
Volume 57, Issue 3, Pages 168-174

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/15563650.2018.1508690

Keywords

Snakebite; climate; environment; incidence; poison control center

Categories

Ask authors/readers for more resources

Background: Climate change effect on flora and fauna has been scientifically documented, but the effect on North American venomous snakebites is unknown. The objectives were to examine Californian snakebite incidence and correlate with weather patterns and climate changes. Methods: A retrospective analysis of snakebites reported to the Californian Poison Control System from 1 September 1997 to 30 September 2017. Venomous snakebite reports were aggregated by caller zip code, and correlated per county with weather data, air temperature, precipitation, population data, eco-regions, and land characteristics. Time series decomposition by seasonality and trend, regression, and autocorrelation were used to assess association between climate variables and incidence. Results: There were 5365 reported venomous snakebites during the study period, with a median age of 37 years (22-51) with 76% male (p < .001, 95% CI 75.6-77.9%). Most snakebite outcomes were coded as minor (1363, 25%) or moderate (2607, 49%), with three deaths. Adjusted for population, the annualized incidence of snakebites statewide slightly decreased (rho = -0.11, p = .65). The snakebite incidence per million people rose after a period of no drought and declined during drought (r = -0.41, p MUCH LESS-THAN .01). Snakebite incidence decreased by 6-month prior drought (-3.8% for each 10% increase in drought), and increased by 18-month prior precipitation (+3.9% for each 10% increase in precipitation). Conclusions: Patterns of precipitation and drought had a significant and predictive effect on snakebites in California over a 20-year period. Snakebite incidence decreased following drought, and increased after precipitation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Emergency Medicine

ECG OF THE MONTH

Kai Li, Hallam Gugelmann, Jeffrey A. Tabas

ANNALS OF EMERGENCY MEDICINE (2015)

Article Anesthesiology

Racial Disparities Across Provider Specialties in Opioid Prescriptions Dispensed to Medicaid Beneficiaries with Chronic Noncancer Pain

Chris Ringwalt, Andrew W. Roberts, Hallam Gugelmann, Asheley Cockrell Skinner

PAIN MEDICINE (2015)

Article Emergency Medicine

Multidisciplinary intervention decreases the use of opioid medication discharge packs from 2 urban EDs

Hallam Gugelmann, Frances S. Shofer, Zachary F. Meisel, Jeanmarie Perrone

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2013)

Letter Toxicology

Acute human toxicity after the ingestion of cabezon, scorpaenichthys marmoratus, roe

Charles W. O'Connell, Rick Clark, Janna H. Villano, Hallam Gugelmann, Jo Ellen Dyer

CLINICAL TOXICOLOGY (2014)

Article Toxicology

'Crazy Monkey' Poisons Man and Dog: Human and canine seizures due to PB-22, a novel synthetic cannabinoid

H. Gugelmann, R. Gerona, C. Li, B. Tsutaoka, K. R. Olson, D. Lung

CLINICAL TOXICOLOGY (2014)

Editorial Material Medicine, General & Internal

Can Prescription Drug Monitoring Programs Help Limit Opioid Abuse?

Hallam M. Gugelmann, Jeanmarie Perrone

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)

Article Clinical Neurology

Differential prescribing of opioid analgesics according to physician specialty for Medicaid patients with chronic noncancer pain diagnoses

Chris Ringwalt, Hallam Gugelmann, Mariana Garrettson, Nabarun Dasgupta, Arlene E. Chung, Scott K. Proescholdbell, Asheley Cockrell Skinner

PAIN RESEARCH & MANAGEMENT (2014)

Article Critical Care Medicine

Beau's Lines After Cardiac Arrest

Hallam M. Gugelmann, David F. Gaieski

THERAPEUTIC HYPOTHERMIA AND TEMPERATURE MANAGEMENT (2013)

Article Pharmacology & Pharmacy

Butanediol Conversion to Gamma-Hydroxybutyrate Markedly Reduced by the Alcohol Dehydrogenase Blocker Fomepizole

Evangelia Liakoni, Hallam Gugelmann, Delia A. Dempsey, Timothy J. Wiegand, Christopher Havel, Peyton Jacob, Neal L. Benowitz

CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)

Article Pharmacology & Pharmacy

Effects of inhaled JAK inhibitor GDC-4379 on exhaled nitric oxide and peripheral biomarkers of inflammation

Hubert Chen, Rebecca Kunder, Yixuan Zou, Tracy Staton, Rui Zhu, Joshua Galanter, Hallam Gugelmann, Ryan Owen, Michele A. Grimbaldeston, Joanna K. Chang, Matthew R. Durk, Avi Eliahu, Mark S. Wilson, David F. Choy, Maria Wilson, Melissa Black, Marjan Doppen, Stacey Kung, Karen Oldfield, Jenny Sparks, Richard Beasley, Irene Braithwaite

Summary: This study assessed the activity of a new inhaled JAK inhibitor, GDC-4379, in patients with mild asthma. The results showed that GDC-4379 treatment led to reductions in FeNO levels and peripheral biomarkers of inflammation, with good tolerability.

PULMONARY PHARMACOLOGY & THERAPEUTICS (2022)

Review Toxicology

Windmills and Pill Mills: Can PDMPs Tilt the Prescription Drug Epidemic?

Hallam Gugelmann, Jeanmarie Perrone, Lewis Nelson

JOURNAL OF MEDICAL TOXICOLOGY (2012)

No Data Available